Insmed Incorporated (NASDAQ:INSM) is one of the best strong buy healthcare stocks to invest in. Mizuho cut the price target on Insmed Incorporated (NASDAQ:INSM) to $204 from $211 on February 24, maintaining an Outperform rating on the shares. The rating update came after the fiscal Q4 report, with the firm stating that the company offered “highly positive comments” on the Brinsupri launch. Insmed (INSM) Soars After Raising $650 million Insmed Incorporated (NASDAQ:INSM) reported its fiscal Q4 and full yea ...